Wave Life Sciences (WVE) Equity Ratio: 2015-2025
Historic Equity Ratio for Wave Life Sciences (WVE) over the last 10 years, with Sep 2025 value amounting to 0.52.
- Wave Life Sciences' Equity Ratio rose 30.60% to 0.52 in Q3 2025 from the same period last year, while for Sep 2025 it was 0.52, marking a year-over-year increase of 30.60%. This contributed to the annual value of 0.59 for FY2024, which is 312.71% up from last year.
- Per Wave Life Sciences' latest filing, its Equity Ratio stood at 0.52 for Q3 2025, which was down 6.50% from 0.55 recorded in Q2 2025.
- In the past 5 years, Wave Life Sciences' Equity Ratio registered a high of 0.60 during Q1 2025, and its lowest value of -0.31 during Q4 2022.
- Its 3-year average for Equity Ratio is 0.21, with a median of 0.14 in 2023.
- Its Equity Ratio has fluctuated over the past 5 years, first crashed by 40,913.58% in 2023, then skyrocketed by 3,414.34% in 2025.
- Wave Life Sciences' Equity Ratio (Quarterly) stood at 0.16 in 2021, then crashed by 296.21% to -0.31 in 2022, then soared by 146.79% to 0.14 in 2023, then skyrocketed by 312.71% to 0.59 in 2024, then surged by 30.60% to 0.52 in 2025.
- Its Equity Ratio was 0.52 in Q3 2025, compared to 0.55 in Q2 2025 and 0.60 in Q1 2025.